ArticleFrontiers in endocrinology2018

TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors.

Barbara Dos Santos Passaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.